on 24 May 2022
Last Applicant/ Owned by
22419 Hamburg
DE
Serial Number
79304082 filed on 21st Dec 2020
Registration Number
6733704 registered on 24th May 2022
Correspondent Address
William E OBrien, Esq.
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Pharmaceutical cost management services Consultation in the field of regulatory compliance with respect to the pharmaceutical and medical products of others; regulatory compliance consulting services as they apply to clinical trials and preclinical drug development Medical and scientific research in the fields of neuroscience, oncology, immunology and inflammation, metabolic diseases and complic Read More
Medical and scientific research in the fields of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases, dermatology, haematology, ophthalmology, rare diseases; conducting clinical trials for others in the field of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases, dermatology, haematology, ophthalmology, rare diseases,; clinical research in the field of neuroscience, oncology, immunology and inflammation, metabolic diseases and complications, respiratory and anti-infective diseases but also in many other indications in the fields of dermatology, haematology, ophthalmology, rare diseases; pharmaceutical research services; medical and scientific research consultation pertaining to pharmacology, toxicology, drug metabolism, pharmacokinetics, bioanalysis, and tablet compression; research of medicines; development of pharmaceutical preparations, formulations, drug substances, drug products, active pharmaceutical ingredients, and medicines; research to develop pharmaceutical products; design and testing of new pharmaceutical products for others
Pharmaceutical cost management services
Consultation in the field of regulatory compliance with respect to the pharmaceutical and medical products of others; regulatory compliance consulting services as they apply to clinical trials and preclinical drug development
No 79304082
No Service Mark
No 515001
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
24th May 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
24th May 2022 | REGISTERED-PRINCIPAL REGISTER |
08th Mar 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
08th Mar 2022 | PUBLISHED FOR OPPOSITION |
16th Feb 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
16th Feb 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
16th Feb 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Feb 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
31st Jan 2022 | EXAMINER'S AMENDMENT ENTERED |
31st Jan 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |